1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
European Journal of Cancer2006Vol. 42(15), pp. 2499–2503
Citations Over TimeTop 10% of 2006 papers
Mathilde C.M. Kouwenhoven, Johan M. Kros, Pim J. French, Elize M. Biemond‐ter Stege, Wilfried J. Graveland, Martin Taphoorn, Alba A. Brandes, Martin J. van den Bent
Related Papers
- → The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy(1992)188 cited
- → Effect of temozolomide on central nervous system relapse in patients with advanced melanoma(2002)104 cited
- → The use of PCV chemotherapy in oligodendrogliomas(2019)1 cited
- → Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma(2008)2 cited
- → Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma(2011)